|
|
|
Tests of a vaccine against allergic successfully
|
Swiss pharmaceutical company announced the successful completion of clinical trials of a vaccine to prevent the development of allergic reactions. Pereprogrammiruyuschaya immune response vaccine protects against allergies to dust mites pollinoza, and possibly with other allergic diseases.
The test vaccine was attended by 40 men and women suffering an allergy to dust mites. 6 weeks half of the participants received weekly injections experimental drug, the rest were injected inactive substance.
The drug increased tolerance to allergens tested nearly 100 times. The beneficial effects have not yet been determined, as testing continued. No allergic vaccine developed by Cytos Biotechnology, does not represent a threat to patients' DNA fragment of the causative agent of tuberculosis.
The coverage of the immune system pereprogrammiruet allergika, adjusting her in a T type that can quickly and painlessly remove imposed antigen the body. In doing so stifled products T-limfotsitov second type of activity related allergic reactions.
Previous studies have shown that a vaccine against allergic can also prevent the development of hay fever (pollinoza) and asthma. One of the new series of tests to evaluate the effectiveness of the drug against food allergies. The developers plan to obtain approval for the use of a vaccine by 2010.
|
|
|
